Skip to content
Review Open access

A NARRATIVE REVIEW OF PATELLOFEMORAL PAIN AND ITS BIOMECHANICAL CONTRIBUTORS, NON PHARMACOLOGICAL MANAGEMENT, AND PREVENTION STRATEGIES RELEVANT TO RUNNERS

Oct 2026 · Genetics and Molecular Research · 0 citations · 53 references

Abstract

Background: Patellofemoral pain (PFP), historically termed patellofemoral pain syndrome (PFPS), is a common and often persistent musculoskeletal condition among physically active individuals and runners. Its development is multifactorial, involving interactions between lower-limb biomechanics, muscle function, training exposure, and environmental demands. Runners exposed to uphill and downhill terrain may experience altered patellofemoral joint loading; however, evidence specifically addressing prevention in hilly-terrain running populations remains limited. Objective: This narrative review synthesised evidence on biomechanical contributors to PFP, non-pharmacological management approaches, and prevention strategies relevant to runners. Methods: Literature was identified through database searches and reference list screening. Searches addressed PFP/PFPS and related terms, biomechanical and aetiological factors, running, and non-pharmacological prevention and management. Of 81 identified records, 39 duplicates were removed, and 42 records underwent title and abstract screening. Eighteen full-text reports were sought, of which 13 were assessed for eligibility; 12 studies were included in the final narrative synthesis. Evidence was interpreted with attention to study design, diagnostic definitions, population characteristics, intervention components, outcome measures, follow-up duration, and applicability to runners. Results: Biomechanical factors associated with PFP include impaired hip and knee muscle function, altered frontal- and transverse-plane lower-limb mechanics, reduced knee flexion during running or functional tasks, and foot-related factors such as increased pronation or rearfoot eversion. These factors should be interpreted cautiously because much of the evidence is cross-sectional and therefore does not establish causality. Exercise therapy and patient education represent the principal components of non-pharmacological management. Hip- and knee-targeted strengthening, combined interventions, patellar taping, foot orthoses, gait retraining, and lower-quadrant manual therapy may provide benefit for selected individuals; however, adjunctive treatments should be tailored to the patient’s clinical presentation. Prevention evidence remains limited. Supervised lower-limb exercise programmes, patellofemoral bracing in selected high-risk populations, and running-technique retraining show potential preventive benefit, whereas evidence for foot orthoses, stretching, footwear modification, and education alone is inconsistent or of low certainty. Conclusion: PFP in runners should be understood as a multifactorial condition rather than the consequence of a single biomechanical abnormality. Individualised exercise-based management and education are the most consistently supported approaches, with adjunctive interventions selected according to patient presentation and running-related demands. High quality prospective studies are required to establish modifiable causal risk factors and to evaluate feasible, context-specific prevention programmes, particularly for runners exposed to sustained uphill and downhill terrain.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.